53 related articles for article (PubMed ID: 1358264)
1. Taxol: a review of its preclinical in vivo antitumor activity.
Rose WC
Anticancer Drugs; 1992 Aug; 3(4):311-21. PubMed ID: 1358264
[TBL] [Abstract][Full Text] [Related]
2. A review: recent advances and future prospects of taxol-producing endophytic fungi.
Zhou X; Zhu H; Liu L; Lin J; Tang K
Appl Microbiol Biotechnol; 2010 May; 86(6):1707-17. PubMed ID: 20358192
[TBL] [Abstract][Full Text] [Related]
3. Paclitaxel: new uses for an old drug.
Zhang D; Yang R; Wang S; Dong Z
Drug Des Devel Ther; 2014; 8():279-84. PubMed ID: 24591817
[TBL] [Abstract][Full Text] [Related]
4. Paclitaxel. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in the treatment of cancer.
Spencer CM; Faulds D
Drugs; 1994 Nov; 48(5):794-847. PubMed ID: 7530632
[TBL] [Abstract][Full Text] [Related]
5. From Traditional Ethnopharmacology to Modern Natural Drug Discovery: A Methodology Discussion and Specific Examples.
Pirintsos S; Panagiotopoulos A; Bariotakis M; Daskalakis V; Lionis C; Sourvinos G; Karakasiliotis I; Kampa M; Castanas E
Molecules; 2022 Jun; 27(13):. PubMed ID: 35807306
[TBL] [Abstract][Full Text] [Related]
6. 5-arylalkynyl-2-benzoyl thiophene: a novel microtubule inhibitor exhibits antitumor activity without neurological toxicity.
Zhuang Y; Yang G; Wu S; Chen J; Guo J; Quan D; Zhang T; Yang Z; Tan S; Ji Y; Chen Z; Lv L
Am J Cancer Res; 2022; 12(1):229-246. PubMed ID: 35141015
[TBL] [Abstract][Full Text] [Related]
7. Intelligent H2S release coating for regulating vascular remodeling.
Lu B; Han X; Zhao A; Luo D; Maitz MF; Wang H; Yang P; Huang N
Bioact Mater; 2021 Apr; 6(4):1040-1050. PubMed ID: 33102945
[TBL] [Abstract][Full Text] [Related]
8. A Novel Resveratrol Based Tubulin Inhibitor Induces Mitotic Arrest and Activates Apoptosis in Cancer Cells.
Thomas E; Gopalakrishnan V; Hegde M; Kumar S; Karki SS; Raghavan SC; Choudhary B
Sci Rep; 2016 Oct; 6():34653. PubMed ID: 27748367
[TBL] [Abstract][Full Text] [Related]
9. Enhanced transfection efficiency and targeted delivery of self-assembling h-R3-dendriplexes in EGFR-overexpressing tumor cells.
Li J; Li S; Xia S; Feng J; Zhang X; Hao Y; Chen L; Zhang X
Oncotarget; 2015 Sep; 6(28):26177-91. PubMed ID: 26309162
[TBL] [Abstract][Full Text] [Related]
10. Delineating intracellular pharmacokinetics of paclitaxel delivered by PLGA nanoparticles.
Li M; Czyszczon EA; Reineke JJ
Drug Deliv Transl Res; 2013 Dec; 3(6):551-61. PubMed ID: 25786375
[TBL] [Abstract][Full Text] [Related]
11. Preclinical efficacy testing for stomach and liver cancers.
Park JW; Baek NS; Lee SC; Oh SJ; Jang SH; Kim IH; Kim DY; Kim HK
Cancer Res Treat; 2014 Apr; 46(2):186-93. PubMed ID: 24851111
[TBL] [Abstract][Full Text] [Related]
12. Bcl-2-enhanced efficacy of microtubule-targeting chemotherapy through Bim overexpression: implications for cancer treatment.
Savry A; Carre M; Berges R; Rovini A; Pobel I; Chacon C; Braguer D; Bourgarel-Rey V
Neoplasia; 2013 Jan; 15(1):49-60. PubMed ID: 23358890
[TBL] [Abstract][Full Text] [Related]
13. Vascular disrupting activity and the mechanism of action of EHT 6706, a novel anticancer tubulin polymerization inhibitor.
Belzacq-Casagrande AS; Bachelot F; De Oliveira C; Coutadeur S; Maurier-Mahé F; Throo E; Chauvignac C; Pognante L; Petibon A; Taverne T; Beausoleil E; Leblond B; Pando MP; Désiré L
Invest New Drugs; 2013 Apr; 31(2):304-19. PubMed ID: 22878926
[TBL] [Abstract][Full Text] [Related]
14. Delayed onset of paresis in rats with experimental intramedullary spinal cord gliosarcoma following intratumoral administration of the paclitaxel delivery system OncoGel.
Tyler BM; Hdeib A; Caplan J; Legnani FG; Fowers KD; Brem H; Jallo G; Pradilla G
J Neurosurg Spine; 2012 Jan; 16(1):93-101. PubMed ID: 22208429
[TBL] [Abstract][Full Text] [Related]
15. Phase I clinical, pharmacokinetic, and pharmacodynamic study of KOS-862 (Epothilone D) in patients with advanced solid tumors and lymphoma.
Konner J; Grisham RN; Park J; O'Connor OA; Cropp G; Johnson R; Hannah AL; Hensley ML; Sabbatini P; Mironov S; Danishefsky S; Hyman D; Spriggs DR; Dupont J; Aghajanian C
Invest New Drugs; 2012 Dec; 30(6):2294-302. PubMed ID: 22072399
[TBL] [Abstract][Full Text] [Related]
16. Differential sensitivity of human glioblastoma LN18 (PTEN-positive) and A172 (PTEN-negative) cells to Taxol for apoptosis.
Zhang R; Banik NL; Ray SK
Brain Res; 2008 Nov; 1239():216-25. PubMed ID: 18804099
[TBL] [Abstract][Full Text] [Related]
17. Antitumour activity of ANG1005, a conjugate between paclitaxel and the new brain delivery vector Angiopep-2.
Régina A; Demeule M; Ché C; Lavallée I; Poirier J; Gabathuler R; Béliveau R; Castaigne JP
Br J Pharmacol; 2008 Sep; 155(2):185-97. PubMed ID: 18574456
[TBL] [Abstract][Full Text] [Related]
18. A mathematical model for analysis of the cell cycle in cell lines derived from human tumors.
Basse B; Baguley BC; Marshall ES; Joseph WR; van Brunt B; Wake G; Wall DJ
J Math Biol; 2003 Oct; 47(4):295-312. PubMed ID: 14523574
[TBL] [Abstract][Full Text] [Related]
19. Growth-inhibiting effects of intralesional docetaxel and paclitaxel on an experimental model of malignant neuroectodermal tumor.
Morales C; Zurita M; Vaquero J
J Neurooncol; 2002 Sep; 59(3):207-12. PubMed ID: 12241116
[TBL] [Abstract][Full Text] [Related]
20. The synthesis, discovery, and development of a highly promising class of microtubule stabilization agents: curative effects of desoxyepothilones B and F against human tumor xenografts in nude mice.
Chou TC; O'Connor OA; Tong WP; Guan Y; Zhang ZG; Stachel SJ; Lee C; Danishefsky SJ
Proc Natl Acad Sci U S A; 2001 Jul; 98(14):8113-8. PubMed ID: 11438750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
